Marsh & McLennan Companies (NYSE:MRSH – Free Report) had its target price upped by Morgan Stanley from $190.00 to $215.00 in a research report sent to investors on Monday morning,Benzinga reports. The brokerage currently has an equal weight rating on the financial services provider’s stock.
Several other analysts also recently weighed in on MRSH. The Goldman Sachs Group decreased their target price on Marsh & McLennan Companies from $197.00 to $191.00 and set a “neutral” rating for the company in a research report on Thursday, October 1st. Citigroup upped their price target on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “neutral” rating in a report on Friday, October 16th. Evercore reduced their price target on shares of Marsh & McLennan Companies from $234.00 to $224.00 in a research note on Thursday, October 8th. Jefferies Financial Group decreased their price objective on shares of Marsh & McLennan Companies from $193.00 to $188.00 and set a “hold” rating for the company in a report on Wednesday, September 30th. Finally, Wells Fargo & Company boosted their price objective on shares of Marsh & McLennan Companies from $183.00 to $197.00 and gave the company an “equal weight” rating in a research report on Friday, October 16th. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $208.63.
Get Our Latest Stock Report on Marsh & McLennan Companies
Marsh & McLennan Companies Stock Performance
Shares of NYSE MRSH opened at $205.38 on Monday. Marsh & McLennan Companies has a fifty-two week low of $156.60 and a fifty-two week high of $214.00. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.09 and a current ratio of 1.09. The stock has a market capitalization of $97.66 billion, a P/E ratio of 24.57, a price-to-earnings-growth ratio of 2.78 and a beta of 0.53. The business has a 50 day simple moving average of $187.05.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last posted its quarterly earnings data on Thursday, October 15th. The financial services provider reported $2.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.96 by $0.07. The company had revenue of $6.86 billion during the quarter. Marsh & McLennan Companies had a return on equity of 33.32% and a net margin of 14.20%. The business’s quarterly revenue was up 8.1% on a year-over-year basis. Sell-side analysts predict that Marsh & McLennan Companies will post 10.49 earnings per share for the current year.
Marsh & McLennan Companies Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, November 13th. Shareholders of record on Thursday, October 1st were issued a $0.99 dividend. This represents a $3.96 annualized dividend and a dividend yield of 1.9%. The ex-dividend date was Thursday, October 1st. Marsh & McLennan Companies’s dividend payout ratio is currently 47.37%.
Insider Buying and Selling at Marsh & McLennan Companies
In other news, VP Stacy Mills sold 1,215 shares of the stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $200.00, for a total transaction of $243,000.00. Following the transaction, the vice president owned 2,705 shares of the company’s stock, valued at approximately $541,000. This represents a 30.99% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Dean Klisura sold 4,194 shares of the firm’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $200.00, for a total value of $838,800.00. Following the transaction, the chief executive officer owned 20,935 shares in the company, valued at approximately $4,187,000. This represents a 16.69% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Fi3 FINANCIAL ADVISORS LLC raised its holdings in shares of Marsh & McLennan Companies by 205.6% in the 3rd quarter. Fi3 FINANCIAL ADVISORS LLC now owns 2,057 shares of the financial services provider’s stock valued at $351,000 after purchasing an additional 1,384 shares in the last quarter. Drake & Associates LLC purchased a new stake in shares of Marsh & McLennan Companies in the 3rd quarter worth approximately $431,000. Innovator Capital Management LLC purchased a new stake in shares of Marsh & McLennan Companies in the 3rd quarter worth approximately $4,501,000. Coastal Bridge Advisors LLC boosted its stake in shares of Marsh & McLennan Companies by 142.8% during the third quarter. Coastal Bridge Advisors LLC now owns 9,529 shares of the financial services provider’s stock valued at $1,627,000 after purchasing an additional 5,604 shares in the last quarter. Finally, Zacks Investment Management boosted its stake in shares of Marsh & McLennan Companies by 2.7% during the third quarter. Zacks Investment Management now owns 207,405 shares of the financial services provider’s stock valued at $35,410,000 after purchasing an additional 5,430 shares in the last quarter. 87.99% of the stock is currently owned by institutional investors.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies, now known as Marsh, is a professional services firm focused on risk, strategy and people. Its businesses help organizations assess and manage risk, arrange insurance and reinsurance, and address workforce and organizational challenges. The company operates through Marsh, an insurance brokerage and risk advisory business; Guy Carpenter, which specializes in reinsurance and related risk services; Mercer, which provides health, wealth and career consulting; and Oliver Wyman, a management consulting firm.
See Also
- Five stocks we like better than Marsh & McLennan Companies
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
